Argus Starts Regeneron Pharma (REGN) at Buy
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $810.24 --0%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 7 | New: 13
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 7 | New: 13
Join SI Premium – FREE
Argus initiated coverage on Regeneron Pharma (NASDAQ: REGN) with a Buy rating and a price target of $375.00.
For an analyst ratings summary and ratings history on Regeneron Pharma click here. For more ratings news on Regeneron Pharma click here.
Shares of Regeneron Pharma closed at $305.92 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wedbush Starts Aktis Oncology (AKTS) at Outperform
- Argus Upgrades APA Corp. (APA) to Buy
- BMO Capital Starts Aktis Oncology (AKTS) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
ArgusSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
